Healthcare

By

David Katz

 | Nov 25, 2014 | 2:30 PM EST

Whether it's acquiring or the acquired, Mylan is building shareholder value.

By

Gary Berman

 | Nov 24, 2014 | 9:23 AM EST

Is the company's stock about to start losing weight?

By

David Katz

 | Nov 21, 2014 | 9:30 AM EST

Its prospects exploded with a breakthrough drug.

By

Bret Jensen

 | Nov 20, 2014 | 8:30 AM EST

For speculative investors.

By

Jim Cramer

 | Nov 17, 2014 | 11:35 AM EST

The CEO of Allergan has created value for shareholders.

By

Bret Jensen

 | Nov 14, 2014 | 10:00 AM EST

Two speculative plays are worthy of consideration.

By

Gary Berman

 | Nov 4, 2014 | 11:35 AM EST

This beloved stock has triggered a long-term overbought signal again.

By

Bret Jensen

 | Oct 31, 2014 | 11:30 AM EDT

Drugs for liver diseases are good opportunities.

By

Kate Stalter

 | Oct 30, 2014 | 2:00 PM EDT

Some growth leaders in the sector are getting technical support.

By

John Reese

 | Oct 30, 2014 | 8:00 AM EDT

Try the Peter Lynch technique in picking stocks.

TrueCar, Inc. (TrueCar) is a data-driven online platform operating a technology infrastruc...
Financial Planning magazine reports that... The Internal Revenue Service is considering re...
MMM is rolling over. Early last week the stock began to fall out of a steep bull cha...
Higher tariffs are a sign of increased floating inventories that will be available for imm...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.